HOME >> BIOLOGY >> NEWS
Male sweat boosts women's hormone levels

nges in women. More cognitive studies need to be done to understand how androstadienone affects female cognitive functions."

One implication of the finding is that there may be better ways to raise cortisol levels in patients with diseases such as Addison's disease, which is characterized by low cortisol. Instead of giving the hormone in pill form, which has side effects such as ulcers and weight gain, "a potential therapeutic mechanism whereby merely smelling synthesized or purified human chemosignals may be used to modify endocrine balance," the authors wrote.

Sweat has been the main focus of research on human pheromones, and in fact, male underarm sweat has been shown to improve women's moods and affect their secretion of luteinizing hormone, which is normally involved in stimulating ovulation. Other studies have shown that when female sweat is applied to the upper lip of other women, these women respond by shifting their menstrual cycles toward synchrony with the cycle of the woman from whom the sweat was obtained.

Androstadienone, a derivative of testosterone that is found in high concentration in male sweat, and in all other body secretions, has garnered the most attention. However, though its effect on a woman's mood, physiological arousal and brain activity suggests that the chemical is a possible pheromone-like signal in humans, its effect on hormone levels was unknown.

Wyart and Sobel set out to test whether androstadienone affects hormone levels as well, focusing on the hormone cortisol. Cortisol is secreted by the body in times of stress, priming the body for "fight or flight."

In two trials, a total of 48 undergraduate women at UC Berkeley were asked to take 20 sniffs from a bottle containing androstadienone, which smells vaguely musky. Over a period of two hours, the volunteers provided five saliva samples from which cortisol levels were determined.

Compared to their response when sniffing a c
'"/>

Contact: Robert Sanders
rsanders@berkeley.edu
510-643-6998
University of California - Berkeley
6-Feb-2007


Page: 1 2 3

Related biology news :

1. Cod in a sweat: Some like it hot!
2. Sociality of sweat bees evolved simultaneously during climate change
3. Study demonstrates Cenestin reduces sleep disturbances/night sweats in post-menopausal women
4. Green tea boosts production of detox enzymes, rendering cancerous chemicals harmless
5. Genetic diversity in honeybee colonies boosts productivity
6. Ground gas gizmo boosts brownfield building
7. ResearchChannel boosts awareness of vital research with video production program
8. Aging boosts chances that a family line will be long-lived
9. Queen bee promiscuity boosts hive health
10. New technique boosts size of proteins that can be analyzed
11. Eating protein boosts hormone that staves off hunger

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Male sweat boosts women hormone levels

(Date:5/7/2015)... , May 7, 2015 ... sensors, FPC1022 and FPC1035, FPC,s smallest touch fingerprint ... are mainly considered for integration on the backside ... smartphone OEMs increased possibilities to integrate touch fingerprint ... size also improves possibilities for module manufacturers to ...
(Date:4/27/2015)... Profile Solutions, Inc. (OTC: PSIQ), a leading ... pleased to announce that Dr Gerry Bedore ... of its scientific advisory board. ... leader in technology-enhanced learning models. He was a co-founder ... studies and books focused on online student success and ...
(Date:4/14/2015)... , April 14, 2015  HYPR Corp. ... Online (FIDO ® ) Alliance tm , an ... FIDO members commit to share technology and collaborate ... that are interoperable, more secure and private, and ... biometric identity verification that protects sensitive user information ...
Breaking Biology News(10 mins):FPC Introduces its Smallest Touch Fingerprint Sensors to Date 2Profile Solutions Names Medicinal Cannabis, Agriculture and Technology Expert Dr. Gerry Bedore to its Scientific Advisory Board 2Profile Solutions Names Medicinal Cannabis, Agriculture and Technology Expert Dr. Gerry Bedore to its Scientific Advisory Board 3Profile Solutions Names Medicinal Cannabis, Agriculture and Technology Expert Dr. Gerry Bedore to its Scientific Advisory Board 4HYPR Corp. Joins the FIDO Alliance 2HYPR Corp. Joins the FIDO Alliance 3
(Date:5/21/2015)... NOVATO, Calif. , May 21, 2015 /PRNewswire-USNewswire/ ... Orrin Hatch (R-UT) and Amy ... Product Extensions Now Accelerating Cures & Treatments, or ... 150 rare disease patient advocacy organizations, this bipartisan ... effective, and affordable medicines to rare disease patients ...
(Date:5/21/2015)... W. R. Grace & Co. ... Worms, Germany has received good manufacturing practice (GMP) ... International Pharmaceutical Excipient Council (IPEC) Foundation. ... SYLOID® FP brand of pharmaceutical grade excipient silica ... Curtis Bay, Maryland (USA) and Sorocaba, Brazil locations. ...
(Date:5/21/2015)... , May 21, 2015  CytRx Corporation (NASDAQ: ... company specializing in oncology, today announced positive updated ... with aldoxorubicin for the treatment of unresectable glioblastoma ...  The open-label, multisite trial is designed to investigate ... patients whose tumors have progressed following prior treatment ...
(Date:5/21/2015)... Research and Markets ( http://www.researchandmarkets.com/research/84975r/2015_global ... "2015 Global Survey on Flow Cytometry Adoption Trends" ... primary goal of this research is to analyze ... Key information the survey seeks to collect include ... predominantly used applications for flow cytometers, respondents, most ...
Breaking Biology Technology:Advocates Cheer Senate Leaders for Introducing Bipartisan Bill to Increase Number of Rare Disease Treatments 2Grace European Facility Receives GMP Excipient Certification for SYLOID® FP Silica Gel 2CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 2CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 3CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 4CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 5CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 6CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 7Global Survey on Flow Cytometry Adoption Trends 2015 2
Cached News: